Institution statistics

AGENZIA ITALIANA DEL FARMACO -  

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 0 1.986.000 57.000 1
2018 0 4.498.931 50.000 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
AGENCE NATIONALE DE SECURITE DU MEDICAMENT ET DES PRODUITS DE SANTE1
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS1
AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN1
ALEXION SERVICES EUROPE SPRL1
ALZHEIMER EUROPE1
AMGEN LIMITED1
AUSTRIAN AGENCY FOR HEALTH AND FOOD SAFETY1
BAYER AKTIENGESELLSCHAFT1
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE1
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL1
COVANCE LABORATORIES1
DEUTSCHES ZENTRUM FUER LUFT UND RAUMFAHRT EV1
ELI LILLY AND COMPANY LIMITED1
EUROPEAN AIDS TREATMENT GROUP EV1
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE1
EUROPEAN PATIENTS' FORUM1
EURORDIS EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION1
F HOFFMANNLA ROCHE1
FEDERAL AGENCY FOR MEDICINES AND HEALTH PRODUCTS1
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES1
FUNDACIO SANT JOAN DE DEU1
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT1
GRUNENTHAL1
H LUNDBECK AS1
HEALTH PRODUCTS REGULATORY AUTHORITY1
HEALTH TECHNOLOGY ASSESSMENT INTERNATIONAL SOCIETY1
INFARMED AUTORIDADE NACIONAL DO MEDICAMENTO E PRODUTOS DA SAUDE IP1
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER1
INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD1
JANSSEN PHARMACEUTICA NV1
LAAKEALAN TURVALLISUUSJA KEHITTAMISKESKUS1
LAKEMEDELSVERKET1
MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY1
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN1
MERCK SHARP & DOHME CORP1
NOVARTIS PHARMA1
NOVO NORDISK1
ORSZAGOS GYOGYSZERESZETI ES ELELMEZESEGESZSEGUGYI INTEZET1
PFIZER LIMITED1
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT1
STATNI USTAV PRO KONTROLU LECIV1
STICHTING VU1
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL1
THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE EUROPEAN MEDICINES AGENCY1
THE MEDICINES AUTHORITY1
THE SYNERGIST1
UCB BIOPHARMA1
URZAD REJESTRACJI PRODUKTOW LECZNICZYCH WYROBOW MEDYCZNYCH I PRODUKTOW BIOBOJCZYCH1
VALSTYBINE VAISTU KONTROLES TARNYBAPRIE LIETUVOS RESPUBLIKOS SVEIKATOS APSAUGOS MINISTERIJOS1
VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV1
ZALU VALSTS AGENTURA1
Constancy:

Total number of partners:53

Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 53

Frequent / Rare Partner Ratio: 0

Diversity:

Subjects:
Subject:No:
Diversity index:0
Categories:
Category:No:

Project overview:

Start dateProjectacronymrolefundingpartners
2019-01-01Strengthening training of academia in regulatory sciences and supporting regulatory scientific advice (STARS) STARSparticipant1.986.00021
2018-03-01Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. PARADIGMparticipant4.498.93134
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum